S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00006708 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

7

Enrollment

NETWORK

Sponsor class

Stopped lack of accrual

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: rituximab
DRUG: carboplatin
DRUG: etoposide
DRUG: ifosfamide

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]